PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions

Adamis Pharmaceuticals Corporation (ADMP)

Equity · Currency in USD · Last updated Feb 23, 2024
SummaryFinancials

Company Info

ISINUS00547W2089
CUSIP00547W208
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic

Highlights

Market Cap$7.25M
EPS-$10.14
Revenue (TTM)$5.02M
Gross Profit (TTM)-$1.43M
EBITDA (TTM)-$17.79M
Year Range$0.45 - $21.70
Target Price$0.42
Short %1.30%
Short Ratio0.02

Share Price Chart


Loading data...

Performance

The chart shows the growth of an initial investment of $10,000 in Adamis Pharmaceuticals Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%Aug 27Sep 03Sep 10Sep 17Sep 24OctoberOct 08Oct 15Oct 22Oct 29Nov 05
-100.00%
-0.66%
ADMP (Adamis Pharmaceuticals Corporation)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ADMP

Adamis Pharmaceuticals Corporation

Return


PeriodReturnBenchmark
Year-To-DateN/A6.65%
1 monthN/A4.57%
6 monthsN/A16.24%
1 yearN/A27.46%
5 years (annualized)N/A12.76%
10 years (annualized)N/A10.68%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2023-40.66%-43.36%-14.94%-25.30%

Risk-Adjusted Performance

This table presents risk-adjusted performance metrics for Adamis Pharmaceuticals Corporation (ADMP) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
ADMP
Adamis Pharmaceuticals Corporation
^GSPC
S&P 500
2.21

Sharpe Ratio


Rolling 12-month Sharpe Ratio-0.500.000.501.00Aug 27Sep 03Sep 10Sep 17Sep 24OctoberOct 08Oct 15Oct 22Oct 29Nov 05
-0.40
0.88
ADMP (Adamis Pharmaceuticals Corporation)
Benchmark (^GSPC)

Dividend History


Adamis Pharmaceuticals Corporation doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%Aug 27Sep 03Sep 10Sep 17Sep 24OctoberOct 08Oct 15Oct 22Oct 29Nov 05
-100.00%
-9.37%
ADMP (Adamis Pharmaceuticals Corporation)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Adamis Pharmaceuticals Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Adamis Pharmaceuticals Corporation was 100.00%, occurring on Sep 25, 2023. The portfolio has not yet recovered.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-100%Nov 23, 19995876Sep 25, 2023
-73.29%Jun 11, 1996271Jul 7, 199795Nov 18, 1997366
-70.07%Nov 28, 1997191Sep 1, 1998296Nov 3, 1999487
-35.19%Aug 25, 199573Dec 12, 1995106May 16, 1996179
-9.72%May 29, 19961May 29, 19964Jun 4, 19965

Volatility Chart

The current Adamis Pharmaceuticals Corporation volatility is 21.30%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%50.00%100.00%150.00%Aug 27Sep 03Sep 10Sep 17Sep 24OctoberOct 08Oct 15Oct 22Oct 29Nov 05
21.30%
4.38%
ADMP (Adamis Pharmaceuticals Corporation)
Benchmark (^GSPC)